CHORDOMA UK
Fundraising in order to (i) fund research into chordoma and improved treatment therefor and (ii) provide information and support to chordoma sufferers.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves increased to £178,454, up from £121,631 in the prior year, driven by a rise in donations and fundraising income. The charity reports no employees and minimal overheads, with trustees receiving no remuneration, only one trustee reimbursed for expenses. The trustees confirm the charity has sufficient funds to meet current requirements and continue operations as a going concern.
What the accounts disclose
“the trustees' fundraising and reserves policy is therefore focused primarily on the funding needs of Professor Flanagan.”
Trustees
- EDWARD JAMES MAJOR
- GERALD FITZ-GIBBON
- JERRY DEL MISSIER
- Richard George Sutton-Mattocks
- Sylvie Marie Louise Leslie
- William Albert Louis Fitz-Gibbon
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/11/2025 | £61k | £5k |
| 30/11/2024 | £42k | £41k |
| 30/11/2023 | £64k | £5k |
| 30/11/2022 | £14k | £19k |
| 30/11/2021 | £22k | £72k |
Common questions
Is CHORDOMA UK financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves increased to £178,454, up from £121,631 in the prior year, driven by a rise in donations and fundraising income. The charity reports no employees and minimal overheads, with trustees receiving no remuneration, only one trustee reimbursed for expenses. The trustees confirm the charity has sufficient funds to meet current requirements and continue operations as a going concern. Its FY2025 accounts were independently examined.